|
|
Biotechnology and Pharmaceuticals - uk directory
|
|
|
|
|
|
| Biotechnology and Pharmaceuticals
|
|
Fumair Ltd : Manufacturers of high quality laboratory fume cupboards, fume extraction systems and associated equipment. |
|
Sci7 : Biotechnology Information Technology |
Latest news for Biotechnology and Pharmaceuticals
|
Momenta Pharmaceuticals Announces Appointment of James R. Sulat to Board of Directors (PrimeNewswire via Yahoo! Finance)
CAMBRIDGE, Mass., June 11, 2008 -- Momenta Pharmaceuticals, Inc. , a biotechnology company specializing in the characterization and engineering of complex drugs, today announced the appointment of James R.
Molecular Insight Pharmaceuticals, Inc. Announces Panel Participation at the BIO 2008 International Convention (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass.----Molecular Insight Pharmaceuticals, Inc. announced today that John E. McCray, Chief Operating Officer of Molecular Insight, will participate in a panel discussion on the strategic in-licensing of late-stage compounds at the upcoming Biotechnology Industry Organization International Convention, being held June 17-20, 2008 in San Diego, CA.
Akela Pharma awarded development contract from Pear Tree Pharmaceuticals, Inc. at its PharmaForm subsidiary (CNW Group via Yahoo! Finance)
Akela Pharma Inc. , a drug development company focused on developing therapies for the inhalation and pain markets, today announced that it has been awarded a development contract from Pear Tree Pharmaceuticals, Inc. at its PharmaForm subsidiary located in Austin, Texas, for the development of two different drug products for treatment of atrophic vaginitis.
Merrimack Pharmaceuticals Raises $60 Million in Private Financing (PR Newswire via Yahoo! Finance)
Merrimack Pharmaceuticals, Inc., a biotechnology company focused on the discovery and development of novel treatments for autoimmune disease and cancer, today announced that it has raised $60 million in a Series F private equity financing.
Molecular Insight Pharmaceuticals, Inc. Initiates Trofex(TM) Phase 1 Trial for the Detection and Staging of Metastatic ... (Business Wire via Yahoo! Finance)
CAMBRIDGE, Mass.----Molecular Insight Pharmaceuticals, Inc. announced today that it has initiated a Phase 1 clinical trial for its Trofex molecular imaging program for the detection and staging of metastatic prostate cancer.
|
Writen by:
|
|
|
